A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer
Clinical trial NCT07739758 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07739758
- Sponsor
- MediLink Therapeutics (Suzhou) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-06-01
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.